F. Edmondson
General Counsel bei ZAI LAB LIMITED
Vermögen: 488 605 $ am 31.05.2024
Profil
F.
Ty Edmondson is currently the Secretary & Chief Legal Officer at Zai Lab Ltd.
Prior to this, he held the position of Secretary, Associate General Counsel & VP at Sumitomo Pharma America, Inc. and Chief Corporation Counsel & Senior Vice President at Biogen, Inc. from 2014 to 2020.
He completed his undergraduate degree at Washington & Lee University in 1988 and obtained his graduate degree from Widener University School of Law in 1993.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ZAI LAB LTD.
0,03% | 14.05.2024 | 261 102 ( 0,03% ) | 488 605 $ | 31.05.2024 |
Aktive Positionen von F. Edmondson
| Unternehmen | Position | Beginn |
|---|---|---|
| ZAI LAB LIMITED | General Counsel | 07.08.2020 |
Ehemalige bekannte Positionen von F. Edmondson
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01.08.2020 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Unternehmenssekretär | - |
Ausbildung von F. Edmondson
| Washington & Lee University | Undergraduate Degree |
| Widener University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| BIOGEN INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
